GWC Technologies Inc. today announced an agreement with Cybeles Life Science under which Cybeles will distribute GWC’s label-free array systems in South East Asia. GWC’s products are used in proteomics analysis, drug discovery research and diagnostics development. A key distinction of GWC’s analysis systems is their superior throughput and greater experimental rigor, which results from their flexible array format.

GWC selected Cybeles Life Sciences based on Cybeles’ successful experience distributing products and providing quality service in GWC’s target markets. Cybeles will now be able to offer GWC’s versatile label-free detection systems to researchers throughout Singapore, Malaysia and Thailand, delivering powerful and affordable solutions for the most rapidly growing areas of life science research.

According to Georg Gottmann, CEO of Cybeles, “ We are proud to have the responsibility for the GWC product line. It will enable Cybeles to expand its business into the protein analysis market, delivering urgently needed capabilities to our expanding base of life science and medical researchers.”

According to Tim Burland, GWC’s President & CEO, “Cybeles Life Science has a team with more than 20 years proven experience in the molecular biotechnology market. The company has excellent application support and customer orientation, along with a successful track record in marketing, sales and support of products for biotechnology research. Moreover, Cybeles carries several lines complementary to GWC’s products, adding significant value to the relationship.” “Especially important,” added Burland, “Cybeles staff have both the scientific background and the technical capabilities to provide the standard of service and support that GWC demands of its partners. We are delighted to welcome Cybeles Life Science to GWC’s worldwide team.”